Status:
COMPLETED
Low-Level Laser in Head and Neck Chronic Lymphedema
Lead Sponsor:
Abramson Cancer Center at Penn Medicine
Conditions:
Head and Neck Cancer
Lymphedema
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the effect of low-level laser treatment (LLLT) on the severity of lymphedema, symptom burden, functional status, and quality of life in HNC survivors.
Detailed Description
Primary aim: To determine the impact of LLLT, as compared to wait-list control, on changes in severity of lymphedema. Secondary aim: To determine the impact of LLLT, as compared to a wait-list contro...
Eligibility Criteria
Inclusion
- \>18 years of age
- \>6 months post HNC treatment
- No evidence of cancer confirmed with imaging tests
- Having head and neck lymphedema with or without fibrosis
- Completion of initial lymphedema therapy
- Lymphedema duration between 3-24 months
- Ability to speak and read English
- Ability to provide informed consent
Exclusion
- Patients will be excluded if they have any of the following medical conditions that would prohibit the safe implementation of LLLT:
- Pregnancy
- Acute infection
- Photosensitivity
- Chronic inflammatory diseases
- Venous thrombosis
- Carotid artery stenosis
- History of severe trauma
- Medication that affects body fluid and electrolyte balance
- Use of high doses of non-steroidal anti-inflammatory drugs
- Pre-existing skin rash, ulceration, open wound in the treatment area
- Active lymphedema therapy or physical therapy
- Allergic and other systemic skin diseases
Key Trial Info
Start Date :
August 19 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2023
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04482855
Start Date
August 19 2021
End Date
June 30 2023
Last Update
November 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania Abramson Cancer Center
Philadelphia, Pennsylvania, United States, 19104